MarketPulse

genomic data

3 articles
The Motley FoolThe Motley Fool··Robert Izquierdo

GeneDx Director's $13.8M Share Bet Signals Confidence Despite $63M Loss

GeneDx board member Keith Meister buys 351,273 shares for $13.8M amid stock decline and major quarterly loss, betting on turnaround.
WGSWGSWWstock declineprofitability concerns
The Motley FoolThe Motley Fool··Jeff Siegel

Three AI-Powered Healthcare Firms Positioned to Disrupt Medicine by 2030

Three tech-driven companies—Tempus AI, Recursion Pharmaceuticals, and Axsome Therapeutics—are positioned to reshape healthcare through AI, precision medicine, and faster drug discovery by 2030.
AXSMRXRXTEMCNS disordersprecision medicine
GlobeNewswire Inc.GlobeNewswire Inc.··Ip Strategy Holdings, Inc.

GenoBank Scales Onchain Genomic Data Platform to 7,000 Users, $6.9M in Tokenized Assets

IP Strategy Holdings' GenoBank platform reaches 7,000 users, 150+ research partnerships, and $6.9M in tokenized genomic assets on the Story blockchain.
IPSTAI infrastructureintellectual property